Here is the latest stock price and chart of Panacea Biotech. For more details, see the Panacea Biotech company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since small-cap stocks interest you, here's a proven approach on investing in small-cap stocks.
Get Details: We are Bullish on These 3 Little-known Stocks
Live BSE Quotes | Jan 22, 2021 09:28:00 AM | ||
---|---|---|---|
Price (Rs)205.55 | Open (Rs) 204.00 | High (Rs) 205.95 | Low (Rs) 204.00 |
% Change-0.56 | Volume 605 | Value (Rs) 124,358 | 52-Week H/L 265.00 / 90.00 |
Live NSE Quotes | Jan 22, 2021 9:29:58 AM | ||
---|---|---|---|
Price (Rs)202.00 | Open (Rs) 203.50 | High (Rs) 205.80 | Low (Rs) 202.00 |
% Change-2.39 | Volume 18,166 | Value (Rs) 3,710,587 | 52-Week H/L 265.00 / 85.95 |
Change | |||||
---|---|---|---|---|---|
1 Day -0.56% | 1 Month -7.93% | 3 Months 13.66% | 1 Year 57.57% | 5 Years (CAGR)* 13.93% | 10 Years (CAGR)* 0.78% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 22.28 | P/E Ratio (x) 9.22 | Market Cap (Rs m) 12,589.94 | P/BV (x) 3.59 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
PANACEA BIOTECH share price is down 0.6% to Rs 205.6 on the BSE. On the NSE, the PANACEA BIOTECH share price is down 2.4% to Rs 202.0. The total volume of shares traded is 0.0 m.
Overall, the broader S&P BSE HEALTHCARE Index is trading down by 0.6%. And the benchmark S&P BSE SENSEX is at 49,515.1 (down 0.2%).
Over the last 30 days, the PANACEA BIOTECH share price is down 1.8%. And over the last one year, PANACEA BIOTECH share price is up 55.4%.
What else is happening in the markets today? Dig in...
The SGX Nifty opened on a negative note today. At 8:10 am, it was trading down by 55 points, or 0.39% lower at 14,580 levels.
Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.
For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.
More Views on NewsWere you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More